Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 43 (75.0%)

Trials by Status

not_yet_recruiting125%
completed250%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_3

Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy

NCT07629635
completedphase_4

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

NCT02193971
unknownphase_4

Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)

NCT04734353
completedphase_4

Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction

NCT03387826

Clinical Trials (4)

Showing 4 of 4 trials
NCT07629635Phase 3

Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy

Not Yet Recruiting
NCT02193971Phase 4

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

Completed
NCT04734353Phase 4

Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)

Unknown
NCT03387826Phase 4

Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4